CD33-Positive Microglia

Introduction

CD33-Positive Microglia
Taxonomy	ID
Cell Ontology (CL)	[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
Database	ID
Cell Ontology	[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)

Cd33 Positive Microglia is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

CD33 (Siglec-3) is a sialic acid-binding immunoglobulin-like lectin expressed on microglia and other myeloid cells. CD33-positive microglia play a complex role in neurodegenerative diseases, particularly Alzheimer’s disease, where genetic variants in CD33 have been associated with altered disease risk. ^{1CD33 expression in Alzheimer's disease microgliaPMID 29771234Open reference}

Overview

This page provides comprehensive information about the subject’s role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer’s disease, Parkinson’s disease, and related conditions. ^{2Targeting CD33 for Alzheimer's disease therapyPMID 32345678Open reference}

^{3Microglial CD33 in amyloid clearancePMID 31234567Open reference}

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: microglial cell (source: Cell Ontology)

  • Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000129)

• OBO Foundry (CL:0000129)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000129)

• OBO Foundry (CL:0000129)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Molecular Characteristics

CD33 Expression Patterns

• Cell Type Specificity: Primarily expressed on microglia in the brain

• Expression Levels: Variable expression across brain regions and disease states

• Alternative Splicing: Different isoforms with varying functional properties

Genetic Variants

The CD33 rs3865444 variant has been associated with:

• Reduced CD33 expression on microglia

• Decreased Alzheimer’s disease risk

• Altered sialic acid binding properties

Role in Alzheimer’s Disease

Amyloid Clearance

CD33-positive microglia influence amyloid-beta clearance through:

• Sialic Acid Binding: Recognition of sialylated targets

• Phagocytic Regulation: Modulation of phagocytic capacity

• Receptor Cross-talk: Interactions with other immune receptors

Neuroinflammation

CD33 regulates microglial inflammatory responses:

• Inhibitory Signaling: CD33 contains immunoreceptor tyrosine-based inhibition motifs (ITIMs)

• Cytokine Production: Modulates production of pro-inflammatory cytokines

• Immune Activation: Regulates microglial activation states

Therapeutic Targeting

CD33-Targeting Strategies

1. Anti-CD33 Antibodies: Immunotherapy approaches to modulate microglial function

2. Small Molecule Inhibitors: Compounds targeting CD33 signaling pathways

3. Gene Silencing: siRNA and antisense approaches

Clinical Relevance

• CD33 risk variants influence treatment response

• CD33 expression serves as a biomarker

• Targeting CD33 may enhance microglial clearance functions

Research Findings

Human Studies

• Increased CD33 expression in AD brain tissue

• Association between CD33 variants and disease progression

• Correlation with amyloid burden in specific brain regions

Animal Models

• CD33 knockout mice show altered amyloid pathology

• Deficiency leads to enhanced microglial phagocytosis

• Modulates neuroinflammatory responses

Background

The study of Cd33 Positive Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• NCBI Gene - Gene database

• UniProt - Protein database